TMO Thermo Fisher Scientific Inc
Price (delayed)
$431.64
Market cap
$162.84B
P/E Ratio
26.03
Dividend/share
$1.6
EPS
$16.58
Enterprise value
$190.11B
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .
Highlights
The stock's price to earnings (P/E) is 26% less than its last 4 quarters average of 35.3 and 19% less than its 5-year quarterly average of 32.0
The debt has decreased by 11% QoQ and by 10% YoY
Thermo Fisher Scientific's quick ratio has decreased by 11% YoY
Key stats
What are the main financial stats of TMO
Market
Valuations
Earnings
Shares outstanding
377.26M
Market cap
$162.84B
Enterprise value
$190.11B
Price to earnings (P/E)
26.03
Price to book (P/B)
3.33
Price to sales (P/S)
3.85
EV/EBIT
22.68
EV/EBITDA
16.55
EV/Sales
4.43
Revenue
$42.88B
Gross profit
$17.7B
Operating income
$7.34B
Net income
$6.34B
EBIT
$8.38B
EBITDA
$11.49B
Free cash flow
$7.32B
Per share
Balance sheet
Liquidity
EPS
$16.58
EPS diluted
$16.53
Free cash flow per share
$19.17
Book value per share
$129.63
Revenue per share
$112.25
TBVPS
$94.07
Total assets
$97.32B
Total liabilities
$47.77B
Debt
$31.28B
Equity
$49.58B
Working capital
$8.81B
Debt to equity
0.63
Current ratio
1.66
Quick ratio
1.03
Net debt/EBITDA
2.37
Margins
Efficiency
Dividend
EBITDA margin
26.8%
Gross margin
41.3%
Net margin
14.8%
Operating margin
17.1%
Return on assets
6.4%
Return on equity
13.2%
Return on invested capital
16%
Return on capital employed
10%
Return on sales
19.5%
Dividend yield
0.37%
DPS
$1.6
Payout ratio
9.7%
TMO stock price
How has the Thermo Fisher Scientific stock price performed over time
Intraday
-0.71%
1 week
-1.18%
1 month
-16.63%
1 year
-24.88%
YTD
-17.03%
QTD
-13.26%
Financial performance
How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.88B
Gross profit
$17.7B
Operating income
$7.34B
Net income
$6.34B
Gross margin
41.3%
Net margin
14.8%
The operating income has grown by 7% YoY and by 2.3% from the previous quarter
Thermo Fisher Scientific's operating margin has increased by 7% YoY
Thermo Fisher Scientific's net income has increased by 6% YoY and by 3.2% from the previous quarter
The net margin has increased by 6% YoY and by 2.1% QoQ
Growth
What is Thermo Fisher Scientific's growth rate over time
Valuation
What is Thermo Fisher Scientific stock price valuation
P/E
26.03
P/B
3.33
P/S
3.85
EV/EBIT
22.68
EV/EBITDA
16.55
EV/Sales
4.43
The stock's price to earnings (P/E) is 26% less than its last 4 quarters average of 35.3 and 19% less than its 5-year quarterly average of 32.0
TMO's EPS is up by 7% year-on-year and by 3.7% since the previous quarter
The P/B is 33% below the 5-year quarterly average of 5.0 and 26% below the last 4 quarters average of 4.5
The company's equity rose by 6% YoY
The P/S is 26% below the 5-year quarterly average of 5.2 and 25% below the last 4 quarters average of 5.1
Efficiency
How efficient is Thermo Fisher Scientific business performance
TMO's ROS is up by 9% year-on-year
TMO's return on invested capital is up by 5% year-on-year
TMO's ROA is up by 3.2% from the previous quarter and by 3.2% YoY
The ROE has contracted by 2.2% YoY
Dividends
What is TMO's dividend history
DPS
$1.6
Dividend yield
0.37%
Payout ratio
9.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Thermo Fisher Scientific financials performed over time
The total assets is 104% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has decreased by 11% YoY
Thermo Fisher Scientific's total liabilities has decreased by 8% YoY and by 7% from the previous quarter
The debt is 37% lower than the equity
Thermo Fisher Scientific's debt to equity has decreased by 16% YoY and by 13% QoQ
The debt has decreased by 11% QoQ and by 10% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.